SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bliss GVS Pharma - Quaterly Results

11 May 2023 Evaluate
With no major difference for the quarter endedMarch 2023 , the total revenue stood at Rs. 1434.19  millions.Net Profit of the company move down -68.04% to Rs. 61.06  millions from Rs. 191.04 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 173.90 millions from 311.15 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1434.19 1383.01 3.70 5983.40 6363.57 -5.97 5983.40 6363.57 -5.97
Other Income 64.79 124.36 -47.90 507.66 326.28 55.59 507.66 326.28 55.59
PBIDT 173.90 311.15 -44.11 1409.21 1418.26 -0.64 1409.21 1418.26 -0.64
Interest 49.73 15.37 223.55 100.57 43.24 132.59 100.57 43.24 132.59
PBDT 124.17 295.78 -58.02 1308.64 1402.47 -6.69 1308.64 1402.47 -6.69
Depreciation 39.74 34.06 16.68 151.73 138.47 9.58 151.73 138.47 9.58
PBT 84.43 261.72 -67.74 1156.91 1264.00 -8.47 1156.91 1264.00 -8.47
TAX 23.37 70.68 -66.94 302.14 337.36 -10.44 302.14 337.36 -10.44
Deferred Tax -24.69 14.27 -273.02 -42.10 7.68 -648.18 -42.10 7.68 -648.18
PAT 61.06 191.04 -68.04 854.77 926.64 -7.76 854.77 926.64 -7.76
Equity 104.15 103.68 0.45 104.15 103.68 0.45 104.15 103.68 0.45
PBIDTM(%) 12.13 22.50 -46.10 23.55 22.29 5.68 23.55 22.29 5.68

Bliss GVS Pharma Share Price

258.35 -0.95 (-0.37%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×